Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

New humanized transgenic mouse model of FNAIT

Jan. 8, 2020

Mim8, an FVIII mimetic antibody, shows promise for hemophilia A

Jan. 7, 2020

Phase II data presented for sevuparin in SCD patients with acute painful vaso-occlusive crisis

Jan. 7, 2020

U.S. researchers present novel coagulation factor VIIa chimera for hemophilia patients

Jan. 2, 2020

Regeneron begins open-label extension study with REGN-3918 in PNH

Jan. 2, 2020

PGC-1alpha as a novel therapeutic target in sickle cell disease

Jan. 2, 2020

Phase I data presented for ambrisentan in sickle cell disease

Jan. 2, 2020

Phase II data presented for efgartigimod in adults with primary ITP

Dec. 31, 2019

UNC-0638 in combination with HRI knockdown leads to induction of fetal hemoglobin

Dec. 31, 2019

CTI BioPharma presents data from dose-finding PAC203 study of pacritinib

Dec. 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...